Fundz

Centese reported raising $525,000 in an initial SEC Form D filing, from an offering of $6.5 Million

PRIVATEMay 12, 2025$525K of $6.5M raised

Amount Raised

$525,000

$525,000 sold, per SEC Form D (first sale May 2, 2025)

Round Type

Seed

OmahaHealth Care

Quick answer

Centese raised $525,000 in a Seed round, dated May 2, 2025. Centese is based in Omaha, Nebraska, United States.

How much did Centese raise?
Centese raised $525,000 in a Seed round on May 2, 2025.
What does Centese do?
Centese is a medical technology company focused on advancing post-operative care through innovative wound management solutions.
Where is Centese based and how big is it?
Centese is based in Omaha, Nebraska, United States. Fundz records about 15 employees.
Who are the decision-makers at Centese?
Fundz holds 1 contact at Centese. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Care around the same time

Companies in the same sectors as Centese that raised within 45 days of this round, from Fundz verified event records.

  • Nuvie raised $450K (Pre-Seed) on June 16, 2025.
  • Firefly Neuroscience raised $1.2M on June 16, 2025.
  • EMVision raised $5M (Grant) on June 16, 2025.
  • Allied OMS raised an undisclosed amount on June 16, 2025.
  • Koios Care raised $1.2M (Seed) on June 16, 2025.
  • Positron raised $75M on June 16, 2025.

Who to call at Centese, and when

A new round usually means Centese is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Centese raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Centese, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Centese. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Centese

Location

4156 S 52ND ST

Omaha, Nebraska, United States

About

Centese is a medical technology company focused on advancing post-operative care through innovative wound management solutions. Their flagship product, Thoraguard, is the first and only FDA-cleared intelligent chest drainage system designed to enhance patient outcomes following cardiothoracic surgery. By integrating smart sensing technology and real-time data analytics, Centese helps clinicians make more informed decisions, improve efficiency, and reduce complications. With a commitment to improving surgical recovery and patient care, Centese is redefining the standard for post-operative drainage systems.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Centese raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Centese's next move

See what Strategic adds

Centese raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.